News Archive - Yadira Galindo

You’ve Got to Move It, Move It

Research from Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego suggests that light-intensity physical activity, including shopping or a casual walk, may protect against mobility disability in older women.

Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic/Racial Groups

Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score (PHS), for predicting age of onset of aggressive prostate cancer.

UC San Diego and San Diego County Test COVID-19 Early Alert System in Schools

In an effort to help schools reduce the risk of COVID-19 outbreaks as they resume in-person instruction, UC San Diego and the County of San Diego are testing the Safer at School Early Alert system, an evidence-informed program to detect SARS-CoV-2 at schools and child care centers.

UC San Diego Health Opens Vaccination Site on University Campus

UC San Diego Health will open a new COVID-19 vaccination site on the main campus of University of California San Diego, serving vaccination-eligible UC San Diego Health patients as well as UC San Diego faculty and staff.

When — Not What — Obese Mice Ate Reduced Breast Cancer Risk

University of California San Diego School of Medicine and Moores Cancer Center researchers report that intermittent fasting reduced breast cancer risk in obese mice.

Youth Using E-cigarettes Three Times as Likely to Become Daily Cigarette Smokers

University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science researchers report that starting tobacco products, including e-cigarettes, before the age of 18 is a major risk factor for people becoming daily cigarette smokers.

New Personalized Immunotherapy Trial Launched Despite COVID-19 Pandemic

Since 2016, Bernard Thurman has undergone traditional treatments, experimental therapies and surgeries to counter the cancer within him, but nothing successfully eradicated the disease. Earlier this year, the oncologists in Los Angeles who were treating him referred Thurman to a personalized cancer therapy trial being developed at Moores Cancer Center at UC San Diego Health.